UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035383
Receipt number R000040318
Scientific Title Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery
Date of disclosure of the study information 2019/01/31
Last modified on 2018/12/27 18:08:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery

Acronym

Catheter of artificial pancreas after esophagectomy

Scientific Title

Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery

Scientific Title:Acronym

Catheter of artificial pancreas after esophagectomy

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To find optimum catheter for blood glucose control with artificial pancreas

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of defective blood sampling

Key secondary outcomes

Problem solving method required when blood sampling failure.
Time taken to recover from blood sampling failure.
Percentage of blood sampling failures time during use of artificial pancreas .


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

A group, intravenous indwelling catheters (Insight, 20 G, 30 mm) manufactured by Becton Dickinson Company

Interventions/Control_2

B group, intravenous indwelling catheter (Insight, 22 G, 32 mm) manufactured by Japan Becton Dickinson and Company

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1. Among patients who underwent esophageal resection, cases in which blood glucose control is performed.
2. A performance status of 0-2 accord
ing to the Eastern Cooperative Oncol
ogy Group (ECOG) scale.
3. An age of 20 years and over.
4. Patients who are considered to survive for more than 3 months from the registration.
5. Vital organ functions are preserved within 14 days prior to entry.
6. Sufficient oral intake.
7. All patients gave written informed
consent.

Key exclusion criteria

1. Obvious infection or inflammation.
2. Serious cardiovascular diseases.
3. Serious concurrent disease such as intestinal palsy, small bowel obstraction, uncontrolable diabetes mellitus, renal failure, liver cirrhosis, and so on.
4. Massive ascites beyond the pelvic cavity or pleural effusion.
5. Women who are pregnant or hope to become pregnant during the study period. Men who wish their partner to become pregnant.
6. Patients judged inappropriate for the study by their physicians.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Kitagawa

Organization

Kochi Medical School

Division name

Department of Surgery

Zip code


Address

Kohasu, Okocho, nankoku, Kochi, 783-8505

TEL

088-880-2371

Email

kitagawah@kochi-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Kitagawa

Organization

Kochi Medical School

Division name

Department of Surgery

Zip code


Address

Kohasu, Okocho, nankoku, Kochi, 783-8505

TEL

088-880-2371

Homepage URL


Email

kitagawah@kochi-u.ac.jp


Sponsor or person

Institute

Kochi Medical School

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 12 Month 27 Day

Date of IRB


Anticipated trial start date

2019 Year 01 Month 04 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 12 Month 27 Day

Last modified on

2018 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040318


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name